Abstract
In conclusion, patients with hairy-cell leukemia may need no therapy for prolonged periods. If they are symptomatic from hypersplenism, they may be expected to benefit from splenectomy. Some patients will have a relapse after splenectomy. At this time, there is no method to predict which patients will have a long term benefit from splenectomy, and we believe that operation should not be recommended as the primary therapy for hairy-cell leukemia.
| Original language | English |
|---|---|
| Pages (from-to) | 829-832 |
| Number of pages | 4 |
| Journal | Surgery Gynecology and Obstetrics |
| Volume | 155 |
| Issue number | 6 |
| State | Published - 1982 |
| Externally published | Yes |